JHS Svendgaard Laboratories share news, announcements and annual reports
NSE: JHSBSE: 532771Personal ProductsSmall Cap
JHS Svendgaard Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 2006
Last close ₹7.99down ₹0.20 (2.44%)BSE ₹8.04
Share price at the NSE close on 30 Oct 2026. Previous close ₹8.19.
30 Oct: open ₹8.38, high ₹8.38, low ₹7.86
52-week range of traded prices to 30 Oct 2026
₹6.26Low, 30 Mar 2026₹13.69High, 1 Oct 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹70 Cr3,087th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.40
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −1.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.08
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 38,311
JHS Svendgaard Laboratories share news and announcements
678 announcements, routine notices left out, newest first. Page 6 of 14.
Nov 2020
Oct 2020
9 Oct · Board meeting
Sep 2020
17 Sep · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 30-Jun-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.16 Sep · Results
15 Sep · Management
1 Sep · Updates
Aug 2020
19 Aug · Management
9 Aug · Management
9 Aug · Management
9 Aug · Amendment to AOA/MOA
Jul 2020
30 Jul · Legal
Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 31-Mar-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. No Segment Reporting. The response of the Company is awaited.29 Jul · Related Party Transactions
11 Jul · Board meeting
Jun 2020
24 Jun · Change in Company Secretary/Compliance Officer
23 Jun · Results
23 Jun · Board meeting
23 Jun · Board meeting
20 Jun · Board meeting
9 Jun · Legal
The exchange asked on 8 Jun 2020
May 2020
Apr 2020
30 Apr · Updates
Feb 2020
11 Feb · Results
11 Feb · Board meeting
Jan 2020
27 Jan · Board meeting
Dec 2019
Nov 2019